BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hemati H, Kaur J, Sobti RC, Trehanpati N. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133+ cells to vincristine and 5-fluorouracil through upregulation of BBC3. Biochem Biophys Res Commun 2020;525:941-7. [PMID: 32173531 DOI: 10.1016/j.bbrc.2020.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu F, Qian Y. The role of CD133 in hepatocellular carcinoma. Cancer Biol Ther 2021;22:291-300. [PMID: 33899676 DOI: 10.1080/15384047.2021.1916381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kumar V, Vashishta M, Kong L, Wu X, Lu JJ, Guha C, Dwarakanath BS. The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. Front Cell Dev Biol 2021;9:650772. [PMID: 33968932 DOI: 10.3389/fcell.2021.650772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Han R, Yang H, Lu L, Lin L. Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis. Sci Rep 2021;11:8626. [PMID: 33883691 DOI: 10.1038/s41598-021-88133-7] [Reference Citation Analysis]
4 Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli MP, Talora C, Screpanti I, Palermo R. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives. Cancers (Basel) 2021;13:5106. [PMID: 34680255 DOI: 10.3390/cancers13205106] [Reference Citation Analysis]
5 Bainrauch A, Šisl D, Markotić A, Ostojić A, Gašparov S, Bralić Lang V, Kovačić N, Grčević D, Mrzljak A, Kelava T. NOTCH3 rs1043996 Polymorphism Is Associated with the Occurrence of Alcoholic Liver Cirrhosis Independently of PNPLA3 and TM6SF2 Polymorphisms. J Clin Med 2021;10:4621. [PMID: 34640639 DOI: 10.3390/jcm10194621] [Reference Citation Analysis]